Stock Analiz

UL Solutions Inc. ULS

Precision Instruments · IPO 2024 · data as of November 13, 2026

$80.36Market cap $16.2B
Open the interactive analysis →

UL Solutions Inc. (ULS) is a healthcare company listed in the US with a market value of about $16.2B. In the twelve months to September 30, 2026 it had revenue of $3.2B and net income of $513M, a net margin of 16.1%.

Its overall Stock Analiz score is 2.6 out of 5 (average). The strongest part is financial health (5/5); the weakest is value (0/5).

Key numbers: a P/E of 31.9, a price to free cash flow of 33.7, a 5-year average ROIC of 22%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 48% below the current price.

Score: 2.6 / 5

Value0/5
Future growth2/5
Track record2/5
Financial health5/5
Shareholder returns4/5

Checks passed

  • Profit margin improving
  • 3-year free cash flow growth above 10% a year
  • 5-year average ROIC above 12%
  • ROE above 15%
  • More cash than debt, or low debt to equity
  • Positive free cash flow
  • Interest covered more than 5 times
  • Debt below 3 years of free cash flow

Checks not passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • Price below intrinsic value (DCF, moderate assumptions)
  • PEG below 1.5
  • Revenue growth above 10% last year
  • 3-year revenue growth above 10% a year
  • Strong R&D investment or growth above 20%

Valuation

P/E (TTM)31.9
Forward P/E32.6
P/FCF33.7
P/S5.1
P/B9.5
EV/EBITDA21.2
PEG—
Dividend yield0.71%
FCF yield3.0%
Shareholder yield0.7%
Intrinsic value vs. price−48%

Growth and quality

Revenue growth (1 yr)6.4%
Revenue growth (5 yrs, per year)—
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)24.7%
Net margin (5-yr avg.)10.8%
ROIC (5-yr avg.)22.1%
Profitable years (of last 10)4
Years paying a dividend4

Financials, last 4 years

Fiscal yearTTM2025202420232022
Revenue$3.2B$3.1B$2.9B$2.7B$2.5B
Net income$513M$325M$326M$260M$293M
Free cash flow$481M$403M$287M$252M$208M
EPS (diluted)$2.52$1.60$1.62$1.30$1.47
Net margin16.1%10.7%11.4%9.7%11.6%
ROIC—19.7%20.9%17.1%30.9%

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

What analysts expect

The average 12-month price target from 12 analysts is $96.45, 20% above the current price; targets range from $81.40 to $115.00; the consensus rating is “Buy”; expected EPS is $2.37 for the fiscal year ending December 31, 2026.

Frequently asked questions

What is UL Solutions’s P/E ratio?

About 31.9, based on the last twelve months of diluted earnings per share (forward P/E about 32.6).

Is UL Solutions stock undervalued?

Our DCF model with moderate assumptions puts its intrinsic value about 48% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.

Does UL Solutions pay a dividend?

Yes. The dividend yield is about 0.71%, and it has paid dividends for 4 years in our data.

Is UL Solutions a good stock to buy?

We do not give buy or sell advice. UL Solutions scores 2.6 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.